317 related articles for article (PubMed ID: 29753159)
41. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
[TBL] [Abstract][Full Text] [Related]
42. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.
Rhee Y; Heung M; Chen B; Chenoweth CE
Infect Control Hosp Epidemiol; 2015 Apr; 36(4):424-30. PubMed ID: 25782897
[TBL] [Abstract][Full Text] [Related]
43. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
[TBL] [Abstract][Full Text] [Related]
44. Central-Line-Associated Bloodstream Infections (CLABSIs) Incidence and the Role of Obesity: A Prospective, Observational Study in Greece.
Tsolakoglou I; Intas G; Stergiannis P; Sakkou A; Chalari E; Tsoumakas K; Elefsiniotis I; Fildissis G
Adv Exp Med Biol; 2020; 1196():11-18. PubMed ID: 32468303
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
46. Descriptive epidemiology of central line-associated bloodstream infections at an academic medical center in Iowa, 2019-2022.
Harrington EM; Trautman K; Davis MB; Varzavand K; Meacham H; Dains A; Marra AR; McDanel J; Kenne L; Hanna B; Murphy JP; Diekema DJ; Wellington M; Brust KB; Kobayashi T; Abosi OJ
Am J Infect Control; 2024 Apr; 52(4):436-442. PubMed ID: 37827243
[TBL] [Abstract][Full Text] [Related]
47. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries.
Rosenthal VD; Maki DG; Rodrigues C; Alvarez-Moreno C; Leblebicioglu H; Sobreyra-Oropeza M; Berba R; Madani N; Medeiros EA; Cuéllar LE; Mitrev Z; Dueñas L; Guanche-Garcell H; Mapp T; Kanj SS; Fernández-Hidalgo R;
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1264-72. PubMed ID: 21029008
[TBL] [Abstract][Full Text] [Related]
48. Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients.
Kelada AS; Foster TB; Gagliano GC; Worley S; Tang A; Arakoni VA; Foster CB
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):377-383. PubMed ID: 35475427
[TBL] [Abstract][Full Text] [Related]
49. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
50. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle.
Guerin K; Wagner J; Rains K; Bessesen M
Am J Infect Control; 2010 Aug; 38(6):430-3. PubMed ID: 20570395
[TBL] [Abstract][Full Text] [Related]
51. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
Yu KC; Jung M; Ai C
Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
[TBL] [Abstract][Full Text] [Related]
52. Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection.
Burnham JP; Rojek RP; Kollef MH
Medicine (Baltimore); 2018 Oct; 97(42):e12782. PubMed ID: 30334966
[TBL] [Abstract][Full Text] [Related]
53. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
Concannon C; van Wijngaarden E; Stevens V; Dumyati G
Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
[TBL] [Abstract][Full Text] [Related]
54. Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Lee KH; Lee JH; Lee JH; Kim DY; Park HS; Choi EJ; Ko SH; Seol M; Lee YS; Kang YA; Jeon M; Baek S; Kang YL; Kim SH; Yun SC; Kim H; Jo JC; Choi Y; Joo YD; Lim SN
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1555-1566. PubMed ID: 28552421
[TBL] [Abstract][Full Text] [Related]
55. The burden of mucosal barrier injury laboratory-confirmed bloodstream infection among hematology, oncology, and stem cell transplant patients.
Metzger KE; Rucker Y; Callaghan M; Churchill M; Jovanovic BD; Zembower TR; Bolon MK
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):119-24. PubMed ID: 25632993
[TBL] [Abstract][Full Text] [Related]
56. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line-associated bloodstream infection rates.
Álvarez-Moreno CA; Valderrama-Beltrán SL; Rosenthal VD; Mojica-Carreño BE; Valderrama-Márquez IA; Matta-Cortés L; Gualtero-Trujillo SM; Rodríguez-Peña J; Linares-Miranda CJ; Gonzalez-Rubio ÁP; Vega-Galvis MC; Riaño-Forero I; Ariza-Ayala BE; García-Laverde G; Susmann O; Mancera-Páez O; Olarte N; Rendón-Campo LF; Astudillo Y; Trullo-Escobar MD; Orellano PW
Am J Infect Control; 2016 Nov; 44(11):e235-e241. PubMed ID: 27317408
[TBL] [Abstract][Full Text] [Related]
57. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
Majhail NS; Brunstein CG; McAvoy S; DeFor TE; Al-Hazzouri A; Setubal D; Arora M; Le CT; Wagner JE; Weisdorf DJ
Biol Blood Marrow Transplant; 2008 Sep; 14(9):985-992. PubMed ID: 18721761
[TBL] [Abstract][Full Text] [Related]
58. Incidence, Risk Factors, and Outcomes of Central Line-Associated Bloodstream Infections in Trauma Patients.
Aryan N; Grigorian A; Jeng J; Kuza C; Kong A; Swentek L; Burruss S; Nahmias J
Surg Infect (Larchmt); 2024 Jun; 25(5):370-375. PubMed ID: 38752327
[No Abstract] [Full Text] [Related]
59. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
Linder LA; Gerdy C; Jo Y; Wilson A
J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness of insertion and maintenance bundles to prevent central-line-associated bloodstream infections in critically ill patients of all ages: a systematic review and meta-analysis.
Ista E; van der Hoven B; Kornelisse RF; van der Starre C; Vos MC; Boersma E; Helder OK
Lancet Infect Dis; 2016 Jun; 16(6):724-734. PubMed ID: 26907734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
